Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-10-21

Clinical Trial Update: Role of EndoFLIP in the Diagnostic Paradigm of Esophagogastric Junction Outflow Obstruction [NA]

View source ↗

Summary

A clinical trial investigating the diagnostic role of EndoFLIP for esophagogastric junction outflow obstruction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Esophagogastric Junction Disorder | NA | Status: WITHDRAWN